14-day Premium Trial Subscription Sign Up For FreeGet Free

ContraFect Corporation Stock Forecast NASDAQ:CFRX

Price Target and Analyst Ratings

Most Recent Rating

On September 09, 2021 "SVB Leerink" gave "$14.00" rating for CFRX. The price target was set to $3.90+4.8%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-09-09 $14.00 Initiated by SVB Leerink $4.04 $3.90+4.8%
2021-07-01 Buy Reiterated by Chardan Capital $4.43
2021-03-31 Speculative Buy Initiated by WBB Securities $4.80 $6.50
2021-03-31 Buy Reiterated by Mizuho $4.80 $10.00
2021-03-16 Buy Target Raised by Chardan Capital $6.32 $15.00 → $17.50
2020-08-26 Buy Reiterated by Maxim Group $5.15 $22.00
2020-07-21 Buy Reiterated by Maxim Group $6.48 $22.00
2020-06-09 Buy Initiated by Mizuho $5.92 $12.00
2020-06-08 Overweight Initiated by Cantor Fitzgerald $5.82

CFRX Stock Trend

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $4.27 will firstly indicate a slower falling rate, but may be the first sign of a trend shift.

Given the current short-term trend, the stock is expected to fall -8.15% during the next 3 months and, with a 90% probability hold a price between $2.77 and $3.93 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-30 $3.01 $3.64 $4.27
2021-10-01 $3.00 $3.63 $4.26
2021-10-04 $3.00 $3.63 $4.26
2021-10-05 $2.99 $3.62 $4.25
2021-10-06 $2.99 $3.61 $4.24
2021-10-07 $2.98 $3.61 $4.24
2021-10-08 $2.97 $3.60 $4.23
2021-10-11 $2.97 $3.60 $4.23
2021-10-12 $2.96 $3.59 $4.22
2021-10-13 $2.96 $3.58 $4.21
2021-10-14 $2.95 $3.58 $4.21
2021-10-15 $2.94 $3.57 $4.20
2021-10-18 $2.94 $3.57 $4.20
2021-10-19 $2.93 $3.56 $4.19
2021-10-20 $2.93 $3.55 $4.18
2021-10-21 $2.92 $3.55 $4.18
2021-10-22 $2.91 $3.54 $4.17
2021-10-25 $2.91 $3.54 $4.17
2021-10-26 $2.90 $3.53 $4.16
2021-10-27 $2.90 $3.52 $4.15
2021-10-28 $2.89 $3.52 $4.15
2021-10-29 $2.88 $3.51 $4.14
2021-11-01 $2.88 $3.51 $4.14
2021-11-02 $2.87 $3.50 $4.13
2021-11-03 $2.87 $3.49 $4.12
2021-11-04 $2.86 $3.49 $4.12
2021-11-05 $2.85 $3.48 $4.11
2021-11-08 $2.85 $3.48 $4.11
2021-11-09 $2.84 $3.47 $4.10
2021-11-10 $2.84 $3.46 $4.09

About ContraFect Corporation

ContraFect ContraFect Corporation, a biotechnology company, focuses on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases in the United States. Its lead product candidates consist of CF-301, a lysin that completed Phase 1 human clinical trials for the treatment of Staph aureus bacteremia, including endocarditis caused by methicillin-resistant or methicillin-susceptible Staph aureus; ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT